Metabolic Tumor Volume Impacts Outcomes With CD30 CAR T-Cell Therapy in Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
Blood Adv 2022 Feb 22;6(4)1255-1263, TJ Voorhees, B Zhao, J Oldan, G Hucks, A Khandani, C Dittus, J Smith, JK Morrison, CJ Cheng, A Ivanova, S Park, TC Shea, AW Beaven, G Dotti, J Serody, B Savoldo, N GroverFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.